These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7682163)

  • 1. Purified human oral mucosal Langerhans cells function as accessory cells in vitro.
    Barrett AW; Ross DA; Goodacre JA
    Clin Exp Immunol; 1993 Apr; 92(1):158-63. PubMed ID: 7682163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presenting capacity of Langerhans cells from rat oral epithelium.
    Hasséus B; Dahlgren U; Bergenholtz G; Jontell M
    J Oral Pathol Med; 1995 Feb; 24(2):56-60. PubMed ID: 7745542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
    Prens EP; Benne K; van Joost T; Benner R
    J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cryopreserved human Langerhans cells.
    Seo KI; Huh CH; Han JH; Youn JI; Lee CH; Lee WJ; Eun HC
    Cryobiology; 2002 Oct; 45(2):118-26. PubMed ID: 12482377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucosal Langerhans' cells.
    Barrett AW; Cruchley AT; Williams DM
    Crit Rev Oral Biol Med; 1996; 7(1):36-58. PubMed ID: 8727106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of flow cytometry in the analysis of CD1a/HLADR+ human oral mucosal Langerhans cells.
    Barrett AW; Ross DA; Goodacre JA
    Oral Dis; 1995 Mar; 1(1):49-53. PubMed ID: 7553381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin.
    Cruchley AT; Speight PM; Williams DM
    Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions.
    Baadsgaard O; Lisby S; Avnstorp C; Clemmensen O; Lange-Vejlsgaard G
    Scand J Immunol; 1990 Sep; 32(3):217-24. PubMed ID: 1698306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells from oral epithelium are more effective in stimulating allogeneic t-cells in vitro than Langerhans cells from skin epithelium.
    Hasséus B; Jontell M; Bergenholtz G; Eklund C; Dahlgren UI
    J Dent Res; 1999 Mar; 78(3):751-8. PubMed ID: 10096450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional variation in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibodies against CD1, HLADR, HLADQ and HLADP.
    Cruchley AT; Williams DM; Farthing PM; Lesch CA; Squier CA
    J Oral Pathol Med; 1989 Oct; 18(9):510-6. PubMed ID: 2481737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cells in nasal mucosa of patients with grass pollen allergy.
    Fokkens WJ; Broekhuis-Fluitsma DM; Rijntjes E; Vroom TM; Hoefsmit EC
    Immunobiology; 1991 Mar; 182(2):135-42. PubMed ID: 1715843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin.
    Hasséus B; Jontell M; Bergenholtz G; Dahlgren UI
    Clin Exp Immunol; 2004 Jun; 136(3):483-9. PubMed ID: 15147350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid purification of human Langerhans cells using paramagnetic microbeads.
    Simon JC; Dittmar HC; de Roche R; Wilting J; Christ B; Schöpf E
    Exp Dermatol; 1995 Jun; 4(3):155-61. PubMed ID: 7551563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of immune cells within the healthy oral mucosa of specific pathogen-free cats.
    Arzi B; Murphy B; Baumgarth N; Vapniarsky N; Nemec A; Naydan DK; Cox DP; Verstraete FJ
    Anat Histol Embryol; 2011 Feb; 40(1):1-10. PubMed ID: 20809918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-presenting capacity in normal human dermis is mainly subserved by CD1a+ cells.
    Sepulveda-Merrill C; Mayall S; Hamblin AS; Breathnach SM
    Br J Dermatol; 1994 Jul; 131(1):15-22. PubMed ID: 7519030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans cells and T-lymphocytes in the normal human ectocervix defined by monoclonal antibodies and electron microscopy.
    Roig de Vargas-Linares C
    Microsc Electron Biol Celular; 1989 Jun; 13(1):53-63. PubMed ID: 2636973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin.
    Baadsgaard O; Lisby S; Wantzin GL; Wulf HC; Cooper KD
    J Immunol; 1989 Jun; 142(12):4213-8. PubMed ID: 2470820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane protein A (OmpA) activates human epidermal Langerhans cells.
    Godefroy S; Corvaia N; Schmitt D; Aubry JP; Bonnefoy JY; Jeannin P; Staquet MJ
    Eur J Cell Biol; 2003 Apr; 82(4):193-200. PubMed ID: 12751905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.